AXIM Biotech
  • Home
  • About
  • Science
    • COVID-19 Testing Research
    • Therapeutics
      • Background
      • Small Molecule Details
      • Findings
      • Product Development
    • Diagnostics
      • Background
      • Solution
      • Clinical Research
  • Investors
    • Company Info
    • News
    • Media
    • Press Releases
    • Presentations
    • SEC Filings
    • Corporate Governance
  • Contact
Select Page

A face mask coated in a biological mousetrap for the virus? Just one of AXIM’s inventions.

by IR Team | Oct 8, 2020 | News

SAN DIEGO (KGTV) — A small San Diego biotech is trying to give face masks an added layer of defense by spraying the liner with a biological bait designed to be a mousetrap for the coronavirus. AXIM Biotechnologies is also developing a next-generation rapid antibody...

Making a better facemask, Axim Biotech looks to be a leader protecting people from COVID-19

by IR Team | Oct 1, 2020 | News

Axim Biotech (OTCQB: AXIM) CEO John Huemoeller joined Steve Darling from Proactive with news the company is working on a number of initiatives around protecting people from COVID-19. One of those is a much better facemask and Huemoeller explains how. Huemoeller also...

World’s First Face Mask Designed to Capture and Deactivate SARS-CoV-2 Could Lower COVID-19 Infection Rate

by IR Team | Sep 30, 2020 | News

By HospiMedica International staff writers Posted on 30 Sep 2020 The outbreak of respiratory infection based pandemic diseases like COVID-19 is fueling global demand for face masks among frontline health workers such as first responders, nurses, and medical...

Coronavirus company news summary – Color receives EUA for Covid-19 self-collection kit – Vivera Pharmaceuticals launches BIOZONE device

by IR Team | Sep 17, 2020 | News

AXIM Biotechnologies has filed an Emergency Use Authorisation (EUA) application with the US Food and Drug Administration (FDA) for its first-in-class rapid diagnostic test for Covid-19. AXIM’s rapid diagnostic test is expected to be the market’s first Covid-19 rapid...

AXIM Biotechnologies files EUA with FDA for Covid-19 rapid diagnostic test for neutralising antibodies

by IR Team | Sep 17, 2020 | News

AXIM’s rapid diagnostic test is expected to be the market’s first Covid-19 rapid diagnostic test for measuring levels of functional neutralising antibodies in a lateral flow assay format. AXIM Biotechnologies, an international healthcare solutions company targeting...

First-in-Class Rapid Diagnostic Test Measures COVID-19 Neutralizing Antibodies in Plasma and Serum

by IR Team | Sep 17, 2020 | News

By HospiMedica International staff writers Posted on 17 Sep 2020 A new rapid diagnostic test is expected to be the market’s first COVID-19 rapid diagnostic test for measuring the levels of functional SARS-CoV-2 neutralizing antibodies in a lateral flow assay format....
« Older Entries

About

Science

Investors

Contact

Success!

Subscribe

  • Follow
  • Follow